Literature DB >> 26228355

Screening and surveillance for occupational cholangiocarcinoma in workers exposed to organic solvents.

Shoji Kubo1, Shigekazu Takemura2, Shogo Tanaka2, Takayoshi Nishioka2, Masahiko Kinoshita2, Genya Hamano2, Tokuji Ito2, Takatsugu Yamamoto3, Makoto Abue4, Masaru Aoki5, Kei Nakagawa6, Susumu Hijioka7, Atsushi Miyamoto8, Yukio Osaki9, Ginji Endo10, Shinji Kumagai11.   

Abstract

PURPOSE: This study aimed to establish an efficient strategy for screening and surveillance for occupational cholangiocarcinoma.
METHODS: We evaluated the consecutive changes in laboratory findings during regular health examinations and in abdominal ultrasonography findings before the diagnosis of occupational cholangiocarcinoma in nine patients. The results of laboratory tests and abdominal ultrasonography at the time of diagnosis were also examined.
RESULTS: In all patients, the serum γ-glutamyl transpeptidase (γ-GTP) activity increased several years before the diagnosis of cholangiocarcinoma. The serum alanine aminotransferase (ALT) activity also increased several years before the diagnosis, following an increase in the serum aspartate aminotransferase (AST) activity in most patients. Abdominal ultrasonography before the diagnosis revealed regional dilatation of the bile ducts, which continued to enlarge. At the time of diagnosis, the γ-GTP, AST, and ALT activities were increased in nine, seven, and seven patients, respectively. The regional dilatation of bile ducts without tumor-induced stenosis, dilated bile ducts due to tumor-induced stenosis, space-occupying lesions, and/or lymph node swelling were observed. The serum concentrations of carbohydrate antigen 19-9 (CA 19-9) and/or carcinoembryonic antigen (CEA) were increased in all patients.
CONCLUSIONS: Regular health examinations with a combination of ultrasonography and laboratory tests including the γ-GTP, AST, ALT, CA 19-9, and CEA levels are useful for screening and surveillance for occupational cholangiocarcinoma.

Entities:  

Keywords:  Health examination; Occupational cholangiocarcinoma; Organic solvent; Screening and surveillance

Mesh:

Substances:

Year:  2015        PMID: 26228355     DOI: 10.1007/s00595-015-1229-9

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  24 in total

1.  Impact of nodal involvement on surgical outcomes of intrahepatic cholangiocarcinoma: a multicenter analysis by the Study Group for Hepatic Surgery of the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kazuhisa Uchiyama; Masakazu Yamamoto; Hiroki Yamaue; Shun-ichi Ariizumi; Taku Aoki; Norihiro Kokudo; Tomoki Ebata; Masato Nagino; Masayuki Ohtsuka; Masaru Miyazaki; Eiichi Tanaka; Satoshi Kondo; Takahiro Uenishi; Shoji Kubo; Hiroshi Yoshida; Michiaki Unno; Satoru Imura; Mitsuo Shimada; Masaki Ueno; Tadahiro Takada
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-05       Impact factor: 7.027

2.  The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.

Authors:  A H Patel; D M Harnois; G G Klee; N F LaRusso; G J Gores
Journal:  Am J Gastroenterol       Date:  2000-01       Impact factor: 10.864

3.  Changes in laboratory test results and diagnostic imaging presentation before the detection of occupational cholangiocarcinoma.

Authors:  Shoji Kubo; Shigekazu Takemura; Chikaharu Sakata; Yorihisa Urata; Takayoshi Nishioka; Akinori Nozawa; Masahiko Kinoshita; Genya Hamano; Yasuni Nakanuma; Ginji Endo
Journal:  J Occup Health       Date:  2014-06-21       Impact factor: 2.708

4.  Short-term prognostic factors for primary sclerosing cholangitis.

Authors:  Takeo Watanabe; Kenji Hirano; Minoru Tada; Hiroyuki Isayama; Suguru Mizuno; Toshihiko Arizumi; Nobuo Toda; Yasuhiko Sugawara; Norihiro Kokudo; Kazuhiko Koike
Journal:  J Hepatobiliary Pancreat Sci       Date:  2015-03-31       Impact factor: 7.027

5.  Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.

Authors:  Y-T Kim; J S Byun; J Kim; Y H Jang; W J Lee; J K Ryu; S W Kim; Y B Yoon; C Y Kim
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb

6.  Hepatic and extrahepatic malignancies in primary sclerosing cholangitis.

Authors:  Annika Bergquist; Anders Ekbom; Rolf Olsson; Dan Kornfeldt; Lars Lööf; Ake Danielsson; Rolf Hultcrantz; Stefan Lindgren; Hanne Prytz; Hanna Sandberg-Gertzén; Sven Almer; Fredrik Granath; Ulrika Broomé
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

7.  Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.

Authors:  J K Ramage; A Donaghy; J M Farrant; R Iorns; R Williams
Journal:  Gastroenterology       Date:  1995-03       Impact factor: 22.682

8.  Case series of 17 patients with cholangiocarcinoma among young adult workers of a printing company in Japan.

Authors:  Shoji Kubo; Yasuni Nakanuma; Shigekazu Takemura; Chikaharu Sakata; Yorihisa Urata; Akinori Nozawa; Takayoshi Nishioka; Masahiko Kinoshita; Genya Hamano; Hiroaki Terajima; Gorou Tachiyama; Yuji Matsumura; Terumasa Yamada; Hiromu Tanaka; Shoji Nakamori; Akira Arimoto; Norifumi Kawada; Masahiro Fujikawa; Hiromitsu Fujishima; Yasuhiko Sugawara; Shogo Tanaka; Hideyoshi Toyokawa; Yuko Kuwae; Masahiko Ohsawa; Shinichiro Uehara; Kyoko Kogawa Sato; Tomoshige Hayashi; Ginji Endo
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-01-13       Impact factor: 7.027

9.  Characteristics of printing company workers newly diagnosed with occupational cholangiocarcinoma.

Authors:  Shoji Kubo; Masahiko Kinoshita; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Takayoshi Nishioka; Genya Hamano; Tokuji Ito; Makoto Abue; Masaru Aoki; Kei Nakagawa; Michiaki Unno; Susumu Hijioka; Toshihisa Fujiyoshi; Yasuhiro Shimizu; Toru Mizuguchi; Ken Shirabe; Akihiro Nishie; Yoshinao Oda; Kenji Takenaka; Tomonari Kobarai; Terumasa Hisano; Akio Saiura; Hiroshi Numao; Mayura Toda; Yuko Kuwae; Yasuni Nakanuma; Ginji Endo
Journal:  J Hepatobiliary Pancreat Sci       Date:  2014-08-03       Impact factor: 7.027

10.  Time course of blood parameters in printing workers with cholangiocarcinoma.

Authors:  Shinji Kumagai; Norio Kurumatani; Akira Arimoto; Gaku Ichihara
Journal:  J Occup Health       Date:  2014-05-15       Impact factor: 2.708

View more
  8 in total

1.  Epidemiology and Risk Factors of Cholangiocarcinoma.

Authors:  Martha M Kirstein; Arndt Vogel
Journal:  Visc Med       Date:  2016-12-01

2.  Liver Cancer Study Group of Japan Clinical Practice Guidelines for Intrahepatic Cholangiocarcinoma.

Authors:  Shoji Kubo; Hiroji Shinkawa; Yoshinari Asaoka; Tatsuya Ioka; Hiroshi Igaki; Namiki Izumi; Takao Itoi; Michiaki Unno; Masayuki Ohtsuka; Takuji Okusaka; Masumi Kadoya; Masatoshi Kudo; Takashi Kumada; Norihiro Kokudo; Michiie Sakamoto; Yoshihiro Sakamoto; Hideyuki Sakurai; Tadatoshi Takayama; Osamu Nakashima; Yasushi Nagata; Etsuro Hatano; Kenichi Harada; Takamichi Murakami; Masakazu Yamamoto
Journal:  Liver Cancer       Date:  2022-02-23       Impact factor: 12.430

3.  Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma.

Authors:  Raksawan Deenonpoe; Prakasit Sa-Ngiamwibool; Sasithorn Watcharadetwittaya; Malinee Thanee; Kitti Intuyod; Thachanan Kongpan; Sureerat Padthaisong; Rungtiwa Nutalai; Yaovalux Chamgramol; Chawalit Pairojkul
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

4.  Spatial analysis of hepatobiliary abnormalities in a population at high-risk of cholangiocarcinoma in Thailand.

Authors:  Kavin Thinkhamrop; Apiporn T Suwannatrai; Nittaya Chamadol; Narong Khuntikeo; Bandit Thinkhamrop; Pongdech Sarakarn; Darren J Gray; Kinley Wangdi; Archie C A Clements; Matthew Kelly
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

5.  Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis.

Authors:  Toru Miyazaki; Hiroji Shinkawa; Shigekazu Takemura; Shogo Tanaka; Ryosuke Amano; Kenjiro Kimura; Go Ohira; Kohei Nishio; Masahiko Kinoshita; Jun Tsuchi; Atsushi Ishihara; Shimpei Eguchi; Daisuke Shirai; Takatsugu Yamamoto; Kenichi Wakasa; Norifumi Kawada; Shoji Kubo
Journal:  Asian Pac J Cancer Prev       Date:  2020-12-01

Review 6.  Occupational cholangiocarcinoma caused by exposure to 1,2-dichloropropane and/or dichloromethane.

Authors:  Shoji Kubo; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Masahiko Kinoshita; Genya Hamano; Tokuji Ito; Masaki Koda; Takanori Aota
Journal:  Ann Gastroenterol Surg       Date:  2017-11-17

7.  The Clinical Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Patients with Occupationalzzm321990Cholangiocarcinoma

Authors:  Masahiko Kinoshita; Shigekazu Takemura; Shogo Tanaka; Hiroji Shinkawa; Genya Hamano; Tokuji Ito; Masaki Koda; Takanori Aota; Yasuni Nakanuma; Yasunori Sato; Shoji Nakamori; Akira Arimoto; Takatsugu Yamamoto; Hideyoshi Toyokawa; Shoji Kubo
Journal:  Asian Pac J Cancer Prev       Date:  2018-07-27

8.  Risk factors and characteristics of young patients with the biliary tract carcinoma: results of a project study for biliary surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery.

Authors:  Kyohei Ariake; Michiaki Unno; Hiroshi Yoshida; Shoji Kubo; Akihiko Horiguchi; Hiroki Yamaue; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2020-07-30       Impact factor: 7.027

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.